Michael Hearne

Michael Hearne

Finansdirektör/CFO på ODONATE, INC.

Förmögenhet: 2 M $ per 2026-05-31

63 år
Health Technology
Commercial Services
Consumer Services

Profil

Michael S.
Hearne
is currently Chief Financial Officer at Kezar Life Sciences, Inc. since 2026, Chief Financial Officer at Aurinia Pharmaceuticals, Inc. since 2026, and Chief Financial Officer at Odonate, Inc. since 2018.
Former roles include Managing Director & Principal at Carson Private Capital, Inc., Partner at Rothstein, Kass & Co. LLC from 2000 to 2008, Partner at Weaver & Tidwell LLP from 2014 to 2015, and Chief Financial & Accounting Officer at La Jolla Pharmaceutical Co. Education includes undergraduate and graduate degrees from Brigham Young University and an undergraduate degree from Texas A&M University conferred in 1989.

Kända innehav i offentliga företag

FöretagDatumAntal aktierVärderingVärderingsdatum
2026-05-18 116 144 ( 0,09 % ) 2 M $ 2026-05-31

Aktiva positioner av Michael Hearne

FöretagPositionStart
ODONATE, INC. Finansdirektör/CFO 2018-11-19
AURINIA PHARMACEUTICALS INC. Finansdirektör/CFO 2026-03-23
KEZAR LIFE SCIENCES, INC. Finansdirektör/CFO 2026-05-11

Tidigare kända positioner av Michael Hearne

FöretagPositionSlut
Företagsledare/Principal 2015-01-01
Företagsledare/Principal 2008-01-01
LA JOLLA PHARMACEUTICAL COMPANY Finansdirektör/CFO -
Privat kapitalinvesterare -
Se detaljerna i Michael Hearnes erfarenhet

Michael Hearnes utbildningar

Erfarenheter
Innehade positioner

Aktiva

Inaktiva

Börsnoterade företag

Privata företag

Relationer

78

Första gradens relationer

9

Företag kopplade till första graden

Man

Kvinna

Styrelseledamöter

Chefer

Kopplade företag

Privata företag9

Health Technology

Commercial Services

Commercial Services

Consumer Services

Consumer Services

Finance

Health Technology

Health Technology

Health Technology

  1. Börsen
  2. Insiders
  3. Michael Hearne